Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

NCT01165944 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Pramlintide

Sponsor

University of Colorado, Denver

Collaborators

[object Object]